Supportive Oncology Journal Articles and Videos
Biosimilars in Oncology
Oncology & Hematology Review, 2016;12(1):22–8 DOI: http://doi.org/10.17925/OHR.2016.12.01.22
Translating Promising Biomarkers into Oncology Clinical Practice
Oncology & Hematology Review, 2015;11(1):14–8 DOI: http://doi.org/10.17925/OHR.2015.11.01.14
Mucositis—Supportive Care During Radiotherapy or Chemoradiotherapy of Head and Neck Cancer
Oncology & Hematology Review, 2015;11(1):50–2 DOI: http://doi.org/10.17925/OHR.2015.11.01.50
Chemotherapy-induced Neuropathy—Where Are We Now?
Oncology & Hematology Review, 2015;11(1):53–5 DOI: http://doi.org/10.17925/OHR.2015.11.01.53
Specialist Physician and Medical Oncologist at The Medical Oncology Centre in Rosebank, Johannesburg, South Africa
Dr Rapoport has presented more than 100 abstracts at South African and international meetings (including ASCO, MASCC and ESMO) and published more than 60 peer reviewed publications with over 2,000 citations. He is a reviewer for numerous scientific medical journals, including Annals of Oncology, Supportive Care in Cancer and Journal of Clinical Oncology.
His fields of interest include cancer supportive care, antiemetics and infections in cancer, breast cancer, solid tumours and new anticancer agents. Dr Rapoport is a member of numerous professional societies, including the South African Society of Medical Oncology (SASMO), the European Society for Medical Oncology (ESMO), the American Society for Medical Oncology (ASCO) and the Multinational Association for Supportive Care in Cancer (MASCC), Chair of the MASCC Infection and Myelosupression Study Group and a member of the MASCC Antiemetic Guidelines Working Group and the MASCC Skin Toxicity Study Group. He is a member of various South African and international pharmaceutical company Advisory Boards as well as Protocol Steering Committee.